nodes	percent_of_prediction	percent_of_DWPC	metapath
Antazoline—Bepridil—hypertension	0.582	1	CrCtD
Antazoline—Trimethaphan—Bepridil—hypertension	0.0479	0.126	CrCrCtD
Antazoline—Aprindine—Quinapril—hypertension	0.0435	0.114	CrCrCtD
Antazoline—Naphazoline—Propranolol—hypertension	0.036	0.0945	CrCrCtD
Antazoline—Alverine—Bepridil—hypertension	0.0297	0.078	CrCrCtD
Antazoline—Diphenidol—Bepridil—hypertension	0.0204	0.0535	CrCrCtD
Antazoline—Dextropropoxyphene—Bepridil—hypertension	0.0204	0.0535	CrCrCtD
Antazoline—Phenoxybenzamine—Bepridil—hypertension	0.0204	0.0535	CrCrCtD
Antazoline—Dextropropoxyphene—Quinapril—hypertension	0.0199	0.0522	CrCrCtD
Antazoline—Tripelennamine—Bepridil—hypertension	0.0194	0.051	CrCrCtD
Antazoline—Fentanyl—Bepridil—hypertension	0.0181	0.0477	CrCrCtD
Antazoline—Fentanyl—Quinapril—hypertension	0.0177	0.0464	CrCrCtD
Antazoline—Cyclizine—Bepridil—hypertension	0.0174	0.0457	CrCrCtD
Antazoline—Fentanyl—Benazepril—hypertension	0.0173	0.0453	CrCrCtD
Antazoline—Benzphetamine—Bepridil—hypertension	0.0143	0.0375	CrCrCtD
Antazoline—Benzyl Benzoate—Bepridil—hypertension	0.0132	0.0347	CrCrCtD
Antazoline—Diphenhydramine—Bepridil—hypertension	0.0127	0.0333	CrCrCtD
Antazoline—Benzyl Benzoate—Benazepril—hypertension	0.0126	0.033	CrCrCtD
Antazoline—Phentolamine—NISCH—hypertension	0.000531	0.122	CrCbGaD
Antazoline—Naphazoline—NISCH—hypertension	0.000433	0.0992	CrCbGaD
Antazoline—Phentolamine—ADRA2B—hypertension	0.000248	0.0568	CrCbGaD
Antazoline—Aprindine—CALM2—hypertension	0.00024	0.055	CrCbGaD
Antazoline—Naphazoline—ADRA2B—hypertension	0.000202	0.0463	CrCbGaD
Antazoline—Bepridil—KCNQ1—hypertension	0.0002	0.0459	CrCbGaD
Antazoline—Aprindine—CALM1—hypertension	0.000155	0.0354	CrCbGaD
Antazoline—Phentolamine—ADRA1A—hypertension	0.000153	0.0352	CrCbGaD
Antazoline—Bepridil—CALM2—hypertension	0.000148	0.034	CrCbGaD
Antazoline—Tolazoline—ADRA2B—hypertension	0.000146	0.0335	CrCbGaD
Antazoline—Phenytoin—CYP11B1—hypertension	0.000142	0.0326	CrCbGaD
Antazoline—Naphazoline—ADRA1A—hypertension	0.000125	0.0287	CrCbGaD
Antazoline—Bepridil—ATP1A1—hypertension	0.000121	0.0278	CrCbGaD
Antazoline—Phenoxybenzamine—CALM2—hypertension	0.000116	0.0265	CrCbGaD
Antazoline—Phentolamine—ADRA2A—hypertension	0.000109	0.0249	CrCbGaD
Antazoline—Bepridil—CALM1—hypertension	9.56e-05	0.0219	CrCbGaD
Antazoline—Tolazoline—ADRA1A—hypertension	9.05e-05	0.0207	CrCbGaD
Antazoline—Naphazoline—ADRA2A—hypertension	8.86e-05	0.0203	CrCbGaD
Antazoline—Phenoxybenzamine—ADRA2B—hypertension	7.69e-05	0.0176	CrCbGaD
Antazoline—Phenoxybenzamine—CALM1—hypertension	7.44e-05	0.0171	CrCbGaD
Antazoline—Benzphetamine—SLC6A2—hypertension	7.07e-05	0.0162	CrCbGaD
Antazoline—Tolazoline—ADRA2A—hypertension	6.4e-05	0.0147	CrCbGaD
Antazoline—Oxaprozin—PTGS1—hypertension	6.19e-05	0.0142	CrCbGaD
Antazoline—Phenytoin—CYP2C18—hypertension	5.82e-05	0.0133	CrCbGaD
Antazoline—Benzphetamine—ADRA1A—hypertension	4.98e-05	0.0114	CrCbGaD
Antazoline—Phenoxybenzamine—ADRA1A—hypertension	4.76e-05	0.0109	CrCbGaD
Antazoline—Diphenhydramine—CYP2C18—hypertension	4.56e-05	0.0104	CrCbGaD
Antazoline—Methadone—CYP2C18—hypertension	4.4e-05	0.0101	CrCbGaD
Antazoline—Modafinil—CYP3A5—hypertension	4.32e-05	0.0099	CrCbGaD
Antazoline—Fentanyl—CYP3A5—hypertension	4.23e-05	0.00968	CrCbGaD
Antazoline—Modafinil—SLC6A3—hypertension	4.15e-05	0.00951	CrCbGaD
Antazoline—Phenytoin—CYP3A5—hypertension	3.83e-05	0.00878	CrCbGaD
Antazoline—Benzphetamine—SLC6A3—hypertension	3.6e-05	0.00824	CrCbGaD
Antazoline—Oxaprozin—PTGS2—hypertension	3.54e-05	0.0081	CrCbGaD
Antazoline—Benzphetamine—ADRA2A—hypertension	3.53e-05	0.00808	CrCbGaD
Antazoline—Phenoxybenzamine—ADRA2A—hypertension	3.37e-05	0.00772	CrCbGaD
Antazoline—Methadone—CYP3A5—hypertension	2.9e-05	0.00664	CrCbGaD
Antazoline—Phenoxybenzamine—ADRB2—hypertension	2.83e-05	0.00649	CrCbGaD
Antazoline—Methadone—CYP19A1—hypertension	2.67e-05	0.00612	CrCbGaD
Antazoline—Diphenhydramine—PTGS1—hypertension	2.23e-05	0.0051	CrCbGaD
Antazoline—HRH1—GPCR downstream signaling—ADRB1—hypertension	1.96e-05	0.000591	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—F2R—hypertension	1.96e-05	0.00059	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NPY1R—hypertension	1.93e-05	0.000581	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—UTS2R—hypertension	1.93e-05	0.000581	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TACR2—hypertension	1.93e-05	0.000581	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—ADRA2A—hypertension	1.93e-05	0.000581	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—F2—hypertension	1.93e-05	0.000581	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GHRL—hypertension	1.92e-05	0.000579	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CALCA—hypertension	1.9e-05	0.000572	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—EDNRB—hypertension	1.89e-05	0.000571	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—TAC1—hypertension	1.88e-05	0.000565	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADORA1—hypertension	1.86e-05	0.00056	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—BDKRB2—hypertension	1.85e-05	0.000558	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CXCR3—hypertension	1.84e-05	0.000554	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ANXA1—hypertension	1.84e-05	0.000554	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—ADRBK1—hypertension	1.83e-05	0.000552	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CNR1—hypertension	1.82e-05	0.000548	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PGF—hypertension	1.79e-05	0.000541	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PPBP—hypertension	1.79e-05	0.000541	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR2B—hypertension	1.79e-05	0.000541	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NEDD4L—hypertension	1.79e-05	0.000541	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—EDNRA—hypertension	1.79e-05	0.000539	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—SST—hypertension	1.79e-05	0.000539	CbGpPWpGaD
Antazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—hypertension	1.78e-05	0.000538	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ADRB1—hypertension	1.78e-05	0.000537	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—DRD3—hypertension	1.78e-05	0.000537	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HTR7—hypertension	1.77e-05	0.000535	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—DRD2—hypertension	1.77e-05	0.000535	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—LEPR—hypertension	1.76e-05	0.000532	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NFATC2—hypertension	1.76e-05	0.000532	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—hypertension	1.76e-05	0.000531	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GCG—hypertension	1.76e-05	0.000529	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—POMC—hypertension	1.76e-05	0.000529	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ADRA2A—hypertension	1.75e-05	0.000528	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GHRL—hypertension	1.74e-05	0.000526	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CALCA—hypertension	1.72e-05	0.000519	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CCL2—hypertension	1.72e-05	0.000518	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ATP2A3—hypertension	1.69e-05	0.000508	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PDE4A—hypertension	1.69e-05	0.000508	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—KNG1—hypertension	1.68e-05	0.000508	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—BDKRB2—hypertension	1.68e-05	0.000507	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AGTR1—hypertension	1.67e-05	0.000505	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ADRBK1—hypertension	1.66e-05	0.000501	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CNR1—hypertension	1.65e-05	0.000498	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ARHGDIA—hypertension	1.64e-05	0.000494	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADRA1A—hypertension	1.64e-05	0.000494	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—INHBA—hypertension	1.64e-05	0.000494	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CXCL10—hypertension	1.64e-05	0.000494	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CALM2—hypertension	1.63e-05	0.000492	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ROCK2—hypertension	1.62e-05	0.000488	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HTR7—hypertension	1.61e-05	0.000486	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—DRD2—hypertension	1.61e-05	0.000486	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GCG—hypertension	1.59e-05	0.000481	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—ADRB2—hypertension	1.59e-05	0.000479	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AVPR1A—hypertension	1.58e-05	0.000476	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CYSLTR1—hypertension	1.58e-05	0.000476	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PRKCE—hypertension	1.57e-05	0.000473	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—LHB—hypertension	1.56e-05	0.00047	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—VAV3—hypertension	1.55e-05	0.000467	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—RGS2—hypertension	1.54e-05	0.000465	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GAL—hypertension	1.54e-05	0.000465	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—KNG1—hypertension	1.53e-05	0.000461	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—UTS2—hypertension	1.52e-05	0.00046	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CMA1—hypertension	1.52e-05	0.00046	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TRH—hypertension	1.52e-05	0.00046	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CRHR1—hypertension	1.52e-05	0.00046	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GNRH1—hypertension	1.52e-05	0.00046	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—VIP—hypertension	1.52e-05	0.00046	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AGTR1—hypertension	1.52e-05	0.000459	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GNB3—hypertension	1.51e-05	0.000456	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AVP—hypertension	1.49e-05	0.00045	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CXCL10—hypertension	1.49e-05	0.000448	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—OXTR—hypertension	1.48e-05	0.000445	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—GNAS—hypertension	1.47e-05	0.000444	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TRPC3—hypertension	1.46e-05	0.000441	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CASR—hypertension	1.46e-05	0.000441	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CX3CR1—hypertension	1.46e-05	0.000441	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—LRP2—hypertension	1.46e-05	0.000441	CbGpPWpGaD
Antazoline—Phenytoin—ALB—hypertension	1.45e-05	0.00332	CrCbGaD
Antazoline—HRH1—Signaling by GPCR—ADRB2—hypertension	1.44e-05	0.000435	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HDAC6—hypertension	1.43e-05	0.000432	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CX3CL1—hypertension	1.43e-05	0.000432	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—BDKRB1—hypertension	1.43e-05	0.000432	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PRKCE—hypertension	1.42e-05	0.00043	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—EDN1—hypertension	1.42e-05	0.000428	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCL5—hypertension	1.41e-05	0.000425	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—VAV3—hypertension	1.41e-05	0.000424	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HSPG2—hypertension	1.41e-05	0.000424	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADM—hypertension	1.39e-05	0.00042	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRKG1—hypertension	1.39e-05	0.00042	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PTH—hypertension	1.39e-05	0.00042	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GABBR1—hypertension	1.39e-05	0.00042	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PDE4D—hypertension	1.39e-05	0.00042	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GNB3—hypertension	1.37e-05	0.000414	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GLP1R—hypertension	1.36e-05	0.00041	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CYBB—hypertension	1.36e-05	0.00041	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TACR1—hypertension	1.36e-05	0.00041	CbGpPWpGaD
Antazoline—HRH1—GPCR ligand binding—CXCL8—hypertension	1.36e-05	0.000409	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AVP—hypertension	1.36e-05	0.000409	CbGpPWpGaD
Antazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—hypertension	1.35e-05	0.000408	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—ADCY5—hypertension	1.35e-05	0.000407	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PRKCG—hypertension	1.34e-05	0.000404	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—GNAS—hypertension	1.34e-05	0.000403	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HRH3—hypertension	1.34e-05	0.000403	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PRKCA—hypertension	1.33e-05	0.000401	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—EDN1—hypertension	1.29e-05	0.000389	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCL5—hypertension	1.28e-05	0.000386	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PRKCD—hypertension	1.27e-05	0.000383	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CCR5—hypertension	1.27e-05	0.000383	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NCF2—hypertension	1.24e-05	0.000375	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—HTR2A—hypertension	1.24e-05	0.000375	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—C3—hypertension	1.24e-05	0.000374	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—ADCY5—hypertension	1.22e-05	0.000369	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PRKCG—hypertension	1.22e-05	0.000367	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NPY—hypertension	1.21e-05	0.000365	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—VWF—hypertension	1.21e-05	0.000365	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PRKCA—hypertension	1.21e-05	0.000364	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AGT—hypertension	1.18e-05	0.000355	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AGTR2—hypertension	1.17e-05	0.000352	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—OXT—hypertension	1.17e-05	0.000352	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CXCL2—hypertension	1.17e-05	0.000352	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR1B—hypertension	1.17e-05	0.000352	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—F2R—hypertension	1.16e-05	0.000348	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TGFBR1—hypertension	1.16e-05	0.000348	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCR5—hypertension	1.15e-05	0.000348	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PRKCD—hypertension	1.15e-05	0.000348	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—HTR2A—hypertension	1.13e-05	0.00034	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—C3—hypertension	1.13e-05	0.00034	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NCF1—hypertension	1.12e-05	0.000337	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—EDNRB—hypertension	1.12e-05	0.000337	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TAC1—hypertension	1.11e-05	0.000334	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—F2—hypertension	1.09e-05	0.000328	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PRKCB—hypertension	1.09e-05	0.000328	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ANXA1—hypertension	1.09e-05	0.000328	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CXCR3—hypertension	1.09e-05	0.000328	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IKBKB—hypertension	1.08e-05	0.000324	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AGT—hypertension	1.07e-05	0.000323	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SST—hypertension	1.06e-05	0.000319	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—EDNRA—hypertension	1.06e-05	0.000319	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CALM1—hypertension	1.05e-05	0.000317	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CYBA—hypertension	1.05e-05	0.000317	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DRD3—hypertension	1.05e-05	0.000317	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FLT1—hypertension	1.05e-05	0.000317	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADRB1—hypertension	1.05e-05	0.000317	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADRA2A—hypertension	1.03e-05	0.000312	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PLAT—hypertension	1.03e-05	0.00031	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GHRL—hypertension	1.03e-05	0.00031	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CALCA—hypertension	1.02e-05	0.000307	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—BDKRB2—hypertension	9.94e-06	0.0003	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—POMC—hypertension	9.92e-06	0.000299	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—F2—hypertension	9.89e-06	0.000298	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PRKCB—hypertension	9.89e-06	0.000298	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADRBK1—hypertension	9.82e-06	0.000296	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CNR1—hypertension	9.75e-06	0.000294	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CALM2—hypertension	9.65e-06	0.000291	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AKT2—hypertension	9.54e-06	0.000288	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—DRD2—hypertension	9.51e-06	0.000287	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR7—hypertension	9.51e-06	0.000287	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GCG—hypertension	9.42e-06	0.000284	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PTPN1—hypertension	9.42e-06	0.000284	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NOTCH2—hypertension	9.24e-06	0.000278	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—KL—hypertension	9.24e-06	0.000278	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ITGAV—hypertension	9.07e-06	0.000273	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NGFR—hypertension	9.07e-06	0.000273	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—KNG1—hypertension	9.04e-06	0.000273	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—POMC—hypertension	9.01e-06	0.000272	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRL—hypertension	8.98e-06	0.000271	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AGTR1—hypertension	8.98e-06	0.000271	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HDAC1—hypertension	8.86e-06	0.000267	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—STK11—hypertension	8.86e-06	0.000267	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CCL2—hypertension	8.81e-06	0.000266	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CXCL10—hypertension	8.78e-06	0.000265	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PLG—hypertension	8.76e-06	0.000264	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—RHOA—hypertension	8.74e-06	0.000264	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AKT2—hypertension	8.66e-06	0.000261	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—PIK3R1—hypertension	8.65e-06	0.000261	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADRB2—hypertension	8.52e-06	0.000257	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRKCE—hypertension	8.42e-06	0.000254	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—VAV3—hypertension	8.31e-06	0.000251	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PDGFA—hypertension	8.31e-06	0.000251	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TGFBR2—hypertension	8.19e-06	0.000247	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GNB3—hypertension	8.12e-06	0.000245	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AVP—hypertension	8.01e-06	0.000241	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—RHOA—hypertension	7.94e-06	0.000239	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—GNAS—hypertension	7.9e-06	0.000238	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—PIK3R1—hypertension	7.86e-06	0.000237	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—APOB—hypertension	7.74e-06	0.000233	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PTK2—hypertension	7.71e-06	0.000232	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—CXCL8—hypertension	7.67e-06	0.000231	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—EDN1—hypertension	7.62e-06	0.00023	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCL5—hypertension	7.56e-06	0.000228	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—LPL—hypertension	7.39e-06	0.000223	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—H2AFX—hypertension	7.34e-06	0.000221	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—RPS6KB1—hypertension	7.32e-06	0.000221	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PDGFRB—hypertension	7.32e-06	0.000221	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ADCY5—hypertension	7.24e-06	0.000218	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRKCG—hypertension	7.19e-06	0.000217	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—ITGB3—hypertension	7.14e-06	0.000215	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRKCA—hypertension	7.14e-06	0.000215	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—YWHAZ—hypertension	7.08e-06	0.000213	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NGF—hypertension	7e-06	0.000211	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SPP1—hypertension	7e-06	0.000211	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—CXCL8—hypertension	6.97e-06	0.00021	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRKCD—hypertension	6.81e-06	0.000205	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCR5—hypertension	6.81e-06	0.000205	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HTR2A—hypertension	6.66e-06	0.000201	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—C3—hypertension	6.65e-06	0.000201	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PDGFB—hypertension	6.48e-06	0.000195	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FGFR1—hypertension	6.44e-06	0.000194	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—HIF1A—hypertension	6.35e-06	0.000191	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AGT—hypertension	6.32e-06	0.000191	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CALM1—hypertension	6.22e-06	0.000187	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—APOE—hypertension	6.19e-06	0.000187	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—LEP—hypertension	6.19e-06	0.000187	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CAV1—hypertension	6.14e-06	0.000185	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—APOA1—hypertension	6.12e-06	0.000185	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—KDR—hypertension	6.07e-06	0.000183	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—F2—hypertension	5.84e-06	0.000176	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PRKCB—hypertension	5.84e-06	0.000176	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FN1—hypertension	5.84e-06	0.000176	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NOTCH1—hypertension	5.72e-06	0.000172	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—POMC—hypertension	5.32e-06	0.00016	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—INS—hypertension	5.29e-06	0.00016	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CCL2—hypertension	5.21e-06	0.000157	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IGF1—hypertension	5.12e-06	0.000154	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AKT2—hypertension	5.12e-06	0.000154	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—EGFR—hypertension	5.09e-06	0.000154	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SERPINE1—hypertension	4.86e-06	0.000147	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—FGF2—hypertension	4.71e-06	0.000142	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—RHOA—hypertension	4.69e-06	0.000141	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PIK3R1—hypertension	4.64e-06	0.00014	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—NOS3—hypertension	4.64e-06	0.00014	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—RELA—hypertension	4.37e-06	0.000132	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MTOR—hypertension	4.28e-06	0.000129	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CXCL8—hypertension	4.12e-06	0.000124	CbGpPWpGaD
Antazoline—HRH1—GPCR downstream signaling—AKT1—hypertension	3.98e-06	0.00012	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—IL6—hypertension	3.91e-06	0.000118	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MMP9—hypertension	3.72e-06	0.000112	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—CDKN1A—hypertension	3.71e-06	0.000112	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—PTEN—hypertension	3.7e-06	0.000112	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MAPK8—hypertension	3.62e-06	0.000109	CbGpPWpGaD
Antazoline—HRH1—Signaling by GPCR—AKT1—hypertension	3.61e-06	0.000109	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—EP300—hypertension	3.53e-06	0.000106	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—SRC—hypertension	3.43e-06	0.000104	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—VEGFA—hypertension	3.34e-06	0.000101	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—MYC—hypertension	3.08e-06	9.28e-05	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TGFB1—hypertension	3.07e-06	9.25e-05	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—EGFR—hypertension	3.01e-06	9.07e-05	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—TP53—hypertension	2.53e-06	7.62e-05	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—IL6—hypertension	2.31e-06	6.97e-05	CbGpPWpGaD
Antazoline—HRH1—Signaling Pathways—AKT1—hypertension	2.13e-06	6.43e-05	CbGpPWpGaD
